Furthermore, when the immune parameters were correlated to the SGR, we did observe the tumor size as a function of the immune response, e.g. smaller tumors appeared to be enriched in CD4+HLA-DR+ T cells in HIS-CRC-BRGS mice treated with combination immunotherapy. Here, CD4 is linked to colorectal carcinoma.